Zobrazeno 1 - 10
of 18
pro vyhledávání: '"J V, Conte"'
Autor:
J B, Orens, T H, Shearon, R S, Freudenberger, R S, Freudenburger, J V, Conte, S M, Bhorade, A, Ardehali
Publikováno v:
American Journal of Transplantation. 6:1188-1197
This article reviews trends in thoracic organ transplantation based on OPTN/SRTR data from 1995 to 2004. The number of active waiting list patients for heart transplants continues to decline, primarily because there are fewer patients with coronary a
Autor:
R C, McLean, S M, Nazarian, T J, Gluckman, S P, Schulman, D R, Thiemann, E P, Shapiro, J V, Conte, J B, Thompson, I, Shafique, K W, McNicholas, T C, Villines, K M, Laws, J J, Rade
Publikováno v:
The Journal of cardiovascular surgery. 52(6)
The aim of the present study was to investigate the relative importance of a wide array of patient demographic, procedural, anatomic and perioperative variables as potential risk factors for early saphenous vein graft (SVG) thrombosis after coronary
Autor:
J V, Conte, William A, Baumgartner
Publikováno v:
Transplantation. 74(7)
Publikováno v:
Annals of transplantation. 5(3)
We performed lung transplantation in nine patients with Scleroderma related lung disease. Patient characteristics included: 7 (78%) females, 6 (67%) with limited and 3 (33%) with diffuse Scleroderma. Pulmonary fibrosis was present in 7 (78%) and pulm
Publikováno v:
Chest. 116(2)
This report describes a patient who developed pulmonary hypertension 6 years after lung transplantation for primary pulmonary hypertension (PPH). Evaluation with right heart catheterization followed by pulmonary angiography, however, demonstrated tha
Autor:
J V, Conte
Publikováno v:
Maryland medical journal (Baltimore, Md. : 1985). 47(5)
Thoracic transplantation has been a clinical option for patients with end-stage heart and lung disease for three decades. Heart, lung, and combined heart-lung transplantations are no longer experimental procedures; they are a standard part of the tre
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 17(7)
Primary pulmonary hypertension (PPH) is a progressive disease with a median survival of less than 3 years from diagnosis. Medical management has typically consisted of anticoagulation and oral calcium channel blocking agents, whereas lung transplanta
Autor:
R E, Girgis, I, Tu, G J, Berry, H, Reichenspurner, V G, Valentine, J V, Conte, A, Ting, I, Johnstone, J, Miller, R C, Robbins, B A, Reitz, J, Theodore
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 15(12)
Acute rejection has emerged as an important risk factor for obliterative bronchiolitis after lung transplantation. We performed a multivariate analysis to assess the impact of additional variables.Seventy-four recipients (48 heart-lung, 18 single-lun
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 15(7)
Adult heart-lung transplantation was initiated at Stanford in 1981 and the first pediatric heart-lung transplantation was done in 1986. Intermediate-term results of pediatric heart-lung transplantation at Stanford University are presented.A retrospec
Publikováno v:
Microscopy and Microanalysis. 7:72-73
The reactive oxygen species (ROS) such as superoxide radical (O2), hydrogen peroxide (H2O2), and hydroxyl radical (OH), plays a critical role in the pathogenesis of hypertension, atherosclerosis, ischemia-reperfusion injury, stroke, myocardial infarc